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antipsychotics and antidepressants, quinolones, and cotrimoxa-
zole). Penicillins are the most appropriate group, and quinolones
should be avoided. DDIs between antibiotics and psychotropic
drugs have been reported to occur in 20% of patients, which means
that DDIs checking is always necessary before prescribing. Psychi-
atric adverse events (e.g., hallucinations, restlessness, insomnia)
have also been seen in patients with mental disorders.
The participants will learn about general recommendations on
antibiotic prescribing in this population, focusing on antibiotics
and psychotropics, supported by evidence-based data and real
clinical pharmacological tools useful for daily practice.
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Predicting the outcomes in psychosis: Recent advances
in molecular profiling, neuroimaging and machine
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The outcome of first-episode psychosis (FEP) varies and may be
predicted by several baseline measures. In the Helsinki Early Psy-
chosis Study, young adults with FEP (n=97) from theHelsinki area in
Finland were broadly assessed as soon as possible after first psychi-
atric contact for psychosis. Age- and gender-matched population
controls were also assessed (n=62). The participants were followed
up via appointments and medical records. We present both pub-
lished and unpublished results on predictors of 12-month clinical,
functional, andmetabolic outcomes.More severe cognitive deficits at
the beginning of treatment predicted several outcomes such as
occupational status and functional level – beyond baseline positive
and affective symptom levels, but notwhen negative symptoms were
accounted for. More severe baseline obsessive-compulsive symp-
toms were predictive of a lower rate of remission, whereas a
higher level of anxiety symptoms predicted better functional
outcome, when the severity of positive symptoms was adjusted
for. Adverse childhood experiences measuring cumulating psy-
chosocial stress did not predict occupational status or functional
level when positive and negative symptoms and neurocognition
were controlled for, whereas in controls having experienced
school bullying was associated with lower functioning. Insulin
resistance in early psychosis appeared as an early marker of
increased vulnerability to weight gain and abdominal obesity in
young adults with FEP. Further, increased waist circumference
predicted worsening low-grade inflammation, increasing further
the cardiovascular risk. In sum, we have found different types of
prognostic markers in FEP. Identifying the individuals at risk of
less favorable outcomes could affect treatment choices in FEP.
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Lipid metabolism has been an area of increased interest in psy-
chosis research, not only due to its link to metabolic comorbid-
ities, but also due to its putative role in the pathophysiology of
psychosis. Lipid disturbances are observed already in the period
preceding the onset of psychosis. For example, we performedmass
spectrometry based lipidomics in a cohort of individuals at clinical
high risk for psychosis (the EU-GEI study) and found that the
individuals who transitioned to psychosis within a 2-year follow-
up period displayed decreased levels of ether phospholipids. This
finding may be of direct (patho)physiological relevance, as ether
phospholipids (particularly plasmalogens, a major subgroup of
ether phospholipids) are highly enriched in the brain, are supplied
to the brain by the liver, havemany structural and functional roles,
and may act as endogenous antioxidants. Accumulating evidence
also suggests that lipid disturbances play a crucial role in the
development of metabolic comorbidities associated with psy-
chotic disorders. Our lipidomic studies have shown that psychotic
patients who rapidly gain weight during follow-up have elevated
triglycerides (TGs) with low double bond count and carbon
number at baseline. These TGs are known to be associated with
non-alcoholic fatty liver disease (NAFLD) and with increased risk
of type 2 diabetes. In conclusion, although the mechanisms link-
ing dysregulation of lipid metabolism with the pathophysiology of
psychosis are currently poorly understood, findings by us and
others suggest that metabolic abnormalities are evident in people
who are vulnerable to psychosis, and to the associated metabolic
comorbidities.
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In theory and practice early intervention has an indisputable role in
the treatment of patients with psychotic disorders, however mod-
ern psychiatrists face challenges in their clinical work to find the
balance between the best practice and available treatment options
in their environment. One of the biggest challenges remains the
implementation of high-cost treatment approaches in healthcare
systems ofmiddle-income countries.Moreover, one very important
aspect to consider when implementing early intervention is to
prepare your team for resistance against the innovation. In coun-
tries where psychiatric treatment is more hospital-oriented and
out-patient care is limited to short face-to-face visits with psychi-
atrists, the system is rigid and unwilling to step up to more
expanded treatment option, such as a team approach of more than
6 members to treat one patient. In Latvia we started our early
intervention programme in 2019 (LAT-EIP), 34 patients enrolled,
and 27 finished the programme. When we compared results
between standard treatment and LAT-EIP, psychiatrist out-patient
visits were comparable to LAT-EIP, but the rate of rehospitalization
and assigned disabilities at 12months follow-up differ dramatically:
in LAT-EIP 7.4% had been readmitted and 7.4%were assigned with
disability vs 36.1% and 34.4% of patients in standard treatment
group, respectively, p<0.05. Nevertheless, the only hospital which
continues to provide early intervention is the one which first
established it. This presentation will try to explain step-by-step
what enhances and what holds back innovation in psychiatry in
one middle-income countries.
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I will attempt to address the issues surrounding the CHR concept in
light of novel data and briefly discuss emerging alternatives. The
root problem of the CHR early invention strategy is the exertion of
reducing early nonspecific (pluripotent) psychopathology to a uni-
dimensional model restricted only to positive psychotic symptoms,
which define the binary categories of CHR and “transition” in help-
seeking populations. This major conceptual handicap undermines
the validity and clinical utility. The core predictor of the
“transition” rate is the degree of the risk-enrichment and not the
CHR status. Even with a significant pretest risk enrichment, the
prognostic accuracy is mediocre. The incidence and “transition”
rates of CHR in the community are very low; therefore, CHR does
not represent a cost-effective clinical target—prevention paradox.
CHR succeeding early pluripotent psychopathology is already late
for intervention. “Transition” is not a categorical progression but a
unidimensional shift in psychotic symptoms, and therefore, influ-
enced by the fluctuation of psychotic symptoms, leading to both
false positives and underestimation of nonpsychotic psychopathol-
ogy. There exists no evidence for a specific effect of any intervention
in preventing “transition”; therefore, CHR is not an ideal treatment
target. Binary “transition” outcome does not represent a valid
phenotype for research as “transition” rates are primarily driven
by the sampling heterogeneity. The multidimensional psychopa-
thology and functioning are more clinically relevant, overarching,
and service-user-centered measures to define individual risk and
outcome. Guided by the public health perspective, a universal early
intervention framework, underscoring improved access to care,
may represent a better strategy.
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Over the past few decades, psychiatry and mental health sciences
have reached several major goals. The importance of mental health
and the huge contribution to the burden of disability produced by
mental and neurological disorders has been recognized by all and
most recently also by the United Nations. Treatment technology
has developed and permits the effective management of most
mental disorders. Progress has also been made in the recognition
of human rights of people with mental illness and those who care
for them. More has to be done in these areas but there are also new
tasks that are before psychiatry. These include the addition of
primary prevention of mental disorders to previous efforts to
ensure secondary and tertiary prevention of mental health prob-
lems; the development of appropriate ways of work in order to cope
with problems of comorbidity of mental and physical disorders;
and a fundamental reorientation of training in psychiatry and
related sciences.
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Recent years have seen a great advancement in the emerging field
of Neural Computation, a study of the brain using neuronal
network models. As a consequence, another field of science is
being developed titled ‘Computational Psychiatry’ where neuro-
nal network models of psychopathology help understand the
possible etiology for mental disorders. With Computational Psy-
chiatry we can begin and reformulate mental disorders as brain
disorders. Etiological diagnosis in psychiatry will be the next
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